DCRI to Partner with Novo Nordisk on Large-Scale Global Cardiovascular Study in Acute Myocardial Infarction – DCRI
November 11, 2023 – By randomizing 10,000 adult patients, ARTEMIS will evaluate the effects of a study medicine versus placebo on cardiovascular outcomes in patients with acute myocardial infarction. Novo Nordisk, in collaboration with the Duke Clinical Research Institute (DCRI), will initiate a global cardiovascular outcomes study called ARTEMIS. The ARTEMIS study will be conducted […]